As an organization accredited by the ACCME, Medscape, LLC, requires everyone who is in a position to control the content of an education activity to disclose all relevant financial relationships with any commercial interest. The ACCME defines "relevant financial relationships" as financial relationships in any amount, occurring within the past 12 months, including financial relationships of a spouse or life partner, that could create a conflict of interest.

Medscape, LLC, encourages Authors to identify investigational products or off-label uses of products regulated by the US Food and Drug Administration, at first mention and where appropriate in the content.

Authors

• 

• Robert J. Myerburg, MD

  Professor of Medicine and Physiology, Miller School of Medicine, University of Miami, Miami, Florida

  Disclosures

  Disclosure: Robert J. Myerburg, MD, has disclosed the following relevant financial relationships:
  Served as an advisor or consultant for: GlaxoSmithKline; sanofi-aventis
  Served as a speaker or a member of a speakers bureau for: sanofi-aventis
  
  Dr. Myerburg does not intend to discuss off-label uses of drugs, mechanical devices, biologics, or diagnostics approved by the US Food and Drug Administration (FDA) for use in the United States.
  
  Dr. Myerburg does not intend to discuss investigational drugs, mechanical devices, biologics, or diagnostics not approved by the FDA for use in the United States.

• 

• Stuart J. Connolly, MD

  Professor of Medicine; Director of Cardiology, McMaster University, Hamilton General Hospital, McMaster Clinic, Hamilton, Ontario

  Disclosures

  Disclosure: Stuart J. Connolly, MD, has disclosed the following relevant financial relationships:
  Served as an advisor or consultant for: Boehringer Ingelheim Pharmaceuticals, Inc.; Bristol-Myers Squibb Company; Merck & Co., Inc.; Portola Pharmaceuticals, Inc.; sanofi-aventis
  Served as a speaker or a member of a speakers bureau for: Boehringer Ingelheim Pharmaceuticals, Inc.; Bristol-Myers Squibb Company; Merck & Co., Inc.; Portola Pharmaceuticals, Inc.; sanofi-aventis
  Received grants for clinical research from: Boehringer Ingelheim Pharmaceuticals, Inc.; Bristol-Myers Squibb Company; Merck & Co., Inc.; Portola Pharmaceuticals, Inc.; sanofi-aventis
  
  Dr. Connolly does intend to discuss off-label uses of drugs, mechanical devices, biologics, or diagnostics approved by the FDA for use in the United States.
  
  Dr. Connolly does intend to discuss investigational drugs, mechanical devices, biologics, or diagnostics not approved by the FDA for use in the United States.

Editors

• Ronald K. Miller, PhD

  Scientific Director, Medscape, LLC

  Disclosures

  Disclosure: Ronald K. Miller, PhD, has disclosed no relevant financial relationships.

• Kathleen Walsh Tulley

  Clinical Editor, Medscape, LLC

  Disclosures

  Disclosure:  Kathleen Walsh Tulley has disclosed no relevant financial relationships.

Steering Committee

• Anne B. Curtis, MD

  Disclosures

  Disclosure: Anne B. Curtis, MD, has disclosed the following relevant financial relationships:
  Served as an advisor or consultant for: sanofi-aventis; Medtronic, Inc.; Biosense Webster, Inc.; St. Jude Medical
  Served as a speaker or a member of a speakers bureau for: sanofi-aventis; Medtronic, Inc.
  Received grants for clinical research from: Medtronic, Inc.; St. Jude Medical

• Jean-Marc Davy, MD

  Disclosures

  Disclosure: Jean-Marc Davy, MD, has disclosed the following relevant financial relationships:
  Served as an advisor or consultant for: sanofi-aventis; Boehringer Ingelheim Pharmaceuticals, Inc.; Medtronic, Inc.; Merck Sharp and Dohme; Novartis Pharmaceuticals Corporation
  Served as a speaker or a member of a speakers bureau for: sanofi-aventis; Boehringer Ingelheim Pharmaceuticals, Inc.; Medtronic, Inc.; Merck Sharp and Dohme; Novartis Pharmaceuticals Corporation
  Received grants for clinical research from: sanofi-aventis; Boehringer Ingelheim Pharmaceuticals, Inc.; Medtronic, Inc.; Merck Sharp and Dohme; Novartis Pharmaceuticals Corporation

• Keith A. A. Fox, MB, ChB

  Disclosures

  Disclosure: Keith A. A. Fox, MB, ChB, has disclosed the following relevant financial relationships:
  Served as an advisor or consultant for: Bayer HealthCare Pharmaceuticals; Johnson & Johnson Pharmaceutical Research & Development, L.L.C.; Eli Lilly and Company
  Received grants for clinical research from: Bayer HealthCare Pharmaceuticals; Johnson & Johnson Pharmaceutical Research & Development, L.L.C.; Eli Lilly and Company

• Paulus Kirchhof, MD

  Disclosures

  Disclosure: Paulus Kirchhof, MD, has disclosed the following relevant financial relationships:
  Served as an advisor or consultant for: AstraZeneca Pharmaceuticals LP; 3M Medica; Bayer HealthCare Pharmaceuticals; Boehringer Ingelheim Pharmaceuticals, Inc.; Boston Scientific; Omron Healthcare, Inc.; Meda Pharmaceuticals, Inc.; Medtronic, Inc.; sanofi-aventis; SERVIER; Siemens; Takeda Pharmaceuticals North America, Inc.; Bayer HealthCare Pharmaceuticals
  Received research grants for: 3M Medica; Meda Pharmaceuticals, Inc.; CV Therapeutics; Medtronic, Inc.; Omron Healthcare, Inc.; sanofi-aventis; St. Jude Medical

• Gerald V. Naccarelli, MD

  Disclosures

  Disclosure: Gerald V. Naccarelli, MD, has disclosed the following relevant financial relationships:
  Served as an advisor or consultant for: Daiichi Sankyo, Inc.; Blue Ash Therapeutics, LLC; Biosense Webster, Inc.; Ortho-McNeil-Janssen Pharmaceuticals, Inc.; Otsuka Pharmaceutical Co., Ltd.; St. Jude Medical; Bristol-Myers Squibb Company; Merck & Co., Inc.; Portola Pharmaceuticals, Inc.; Boehringer Ingelheim Pharmaceuticals, Inc.; Pfizer Inc.; AstraZeneca Pharmaceuticals LP; Medtronic, Inc.; sanofi-aventis; Gilead Sciences, Inc.; Novartis Pharmaceuticals Corporation; Xention; GlaxoSmithKline; BioCritique
  Received grants for clinical research from: GlaxoSmithKline; Boehringer Ingelheim Pharmaceuticals, Inc.; Astellas Pharma, Inc.

• Carl J. Pepine, MD

  Disclosures

  Disclosure: Carl J. Pepine, MD, has disclosed the following relevant financial relationships:
  Served as an advisor or consultant for: Abbott Laboratories; Amorcyte, Inc.; Angioblast Systems; Boehringer Ingelheim Pharmaceuticals, Inc.; Forest Laboratories, Inc.; Eli Lilly and Company; Medtelligence, LLC; NicOx; Novartis Pharmaceuticals Corporation; sanofi-aventis; SLACK Incorporated
  Received grants for clinical research from: GlaxoSmithKline; InfraReDx, Inc.; Pfizer Inc

• Eric Prystowsky, MD

  Disclosures

  Disclosure: Eric N. Prystowsky, MD, has disclosed the following relevant financial relationships:
  Served as an advisor or consultant for: Medtronic, Inc.; Boehringer Ingelheim Pharmaceuticals, Inc.; C. R. Bard, Inc.; sanofi-aventis; Stereotaxis, Inc.; CardioNet
  Served as a speaker or member of a speakers bureau for: BIOTRONIK
  Received grants for fellow training from: Medtronic, Inc.; Boston Scientific; St. Jude Medical
  Owns stock, stock options, or bonds from: CardioNet; Stereotaxis, Inc.

CME Reviewer

• Nafeez Zawahir, MD

  CME Clinical Director, Medscape, LLC

  Disclosures

  Disclosure: Nafeez Zawahir, MD, has disclosed no relevant financial relationships.

Peer Reviewer

This activity has been peer reviewed and the reviewer has disclosed no relevant financial relationship.